RTOG 0522: Huge investment in patients and resources and no benefit with addition of cetuximab to radiotherapy-why did this occur?

Douglas Adkins, Jessica Ley, Tanya M. Wildes, Loren Michel

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	1223
Number of pages	1
Journal	Journal of Clinical Oncology
Volume	33
Issue number	10
DOIs	https://doi.org/10.1200/JCO.2014.59.6908
State	Published - Apr 1 2015

Access to Document

@article{5db95abaab054570a0efd64283d0cd71,

title = "RTOG 0522: Huge investment in patients and resources and no benefit with addition of cetuximab to radiotherapy-why did this occur?",

author = "Douglas Adkins and Jessica Ley and Wildes, {Tanya M.} and Loren Michel",

year = "2015",

month = apr,

day = "1",

doi = "10.1200/JCO.2014.59.6908",

language = "English",

volume = "33",

pages = "1223",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

number = "10",

}

TY - JOUR

T1 - RTOG 0522

T2 - Huge investment in patients and resources and no benefit with addition of cetuximab to radiotherapy-why did this occur?

AU - Adkins, Douglas

AU - Ley, Jessica

AU - Wildes, Tanya M.

AU - Michel, Loren

PY - 2015/4/1

Y1 - 2015/4/1

UR - http://www.scopus.com/inward/record.url?scp=84927163616&partnerID=8YFLogxK

U2 - 10.1200/JCO.2014.59.6908

DO - 10.1200/JCO.2014.59.6908

M3 - Letter

C2 - 25713440

AN - SCOPUS:84927163616

SN - 0732-183X

VL - 33

SP - 1223

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 10

ER -